EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Long or short? Telomere length and pancreatic cancer and its precursor lesions, a narrative review

Daniele Campa, Alessio Felici, Chiara Corradi, Giulia Peduzzi, Manuel Gentiluomo iD, Riccardo Farinella, Cosmeri Rizzato

Mutagenesis · 2025

DOI: 10.1093/mutage/gead034 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Mutagenesis, 2025. Verfasst von Daniele Campa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, University of Pisa, Pisa, Italy. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Telomere, Telomere Homeostasis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: Associazione Italiana per la Ricerca sul Cancro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) is the most common and lethal form of pancreatic cancer, with a survival approaching only 11% at 5 years after diagnosis. In the last 15 years, telomere length (TL) measured in leukocyte (LTL) has been studied in relation to PDAC risk. The majority of the studies reported an association between short LTL and increased PDAC risk, but the results are heterogeneous. Genome-wide association studies have identified several single-nucleotide polymorphisms (SNPs) in the telomerase reverse transcriptase (TERT) gene as susceptibility loci for PDAC. Polygenic risk scores computed using SNPs associated with LTL have been tested in relation to PDAC susceptibility with various methods and giving contrasting results. The aim of this review is to analyze all publications carried out specifically on LTL, considering LTL measured with qPCR and with genetic proxies, and PDAC risk. Additionally, we will give an overview of the most relevant associations between SNPs in telomere-associated genes and PDAC, to answer the question shorter or longer? Which one of the two is associated with PDAC risk?

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsCarcinoma, Pancreatic DuctalTelomereTelomere HomeostasisTelomere ShorteningHumansPolymorphism, Single NucleotideTelomeraseGenetic Predisposition to DiseaseGenome-Wide Association StudyLeukocytes

Stichwörter der Autor:innen

Mendelian randomizationPDACSNPspancreatic cancersusceptibilitytelomere lengthtelomeres

Substanzen

TelomeraseTERT protein, human

Autor:innen und Institutionen

  • Department of Biology, University of Pisa, Pisa, Italy.

ORCID-Profile: Manuel Gentiluomo

Förderung

  • Associazione Italiana per la Ricerca sul Cancro

Zitieren

APA

Campa, D., Felici, A., Corradi, C., Peduzzi, G., Gentiluomo, M., Farinella, R., & Rizzato, C. (2025). Long or short? Telomere length and pancreatic cancer and its precursor lesions, a narrative review. Mutagenesis. https://doi.org/10.1093/mutage/gead034

Vancouver

Campa D, Felici A, Corradi C, Peduzzi G, Gentiluomo M, Farinella R, et al. Long or short? Telomere length and pancreatic cancer and its precursor lesions, a narrative review. Mutagenesis. 2025. doi:10.1093/mutage/gead034

BibTeX
@article{Campa2025,
  author = {Campa, Daniele and Felici, Alessio and Corradi, Chiara and Peduzzi, Giulia and Gentiluomo, Manuel and Farinella, Riccardo and Rizzato, Cosmeri},
  title = {Long or short? Telomere length and pancreatic cancer and its precursor lesions, a narrative review},
  journal = {Mutagenesis},
  year = {2025},
  doi = {10.1093/mutage/gead034}
}
Kostenlos starten →